{
  "@context": "https://frontierpicks.com/schemas/dossier.v1.json",
  "ticker": "COCO",
  "name": "The Vita Coco Company, Inc.",
  "url": "https://frontierpicks.com/dossiers/COCO/",
  "json_url": "https://frontierpicks.com/dossiers/COCO.json",
  "status": "DORMANT",
  "current_conviction": "LOW",
  "graded_conviction": "LOW",
  "archetype": {
    "code": "a1",
    "n": 1
  },
  "current_thesis": "Q2 FY26 (2026-07-23) beat on every line — net sales $216.2M +28.1%, EPS $0.82 vs ~$0.55, FY guide raised to $790–805M — and the stock still closed $62.25 on 2026-08-07, -25.9% from the post-print high. Beat-and-raise absorbed by sellers; no dated catalyst until an unannounced Q3 print, and the ~$60 April gap shelf is the last structure standing.",
  "invalidation_trigger": "A weekly close below $60 fills the late-April Q1 breakaway-gap shelf and retraces the entire post-Q1 re-rate. Secondary: a Q3 FY26 print with gross margin at or under the ~40% FY guide once the ~700bps tariff-refund benefit is out.",
  "catalyst_date": null,
  "outcome": "PLAYED_OUT",
  "outcome_date": "2026-08-17",
  "invalidation_fired": false,
  "themes": [
    "consumer-discretionary-rotation",
    "cyclical-industrials"
  ],
  "tags": [],
  "sources": [],
  "notes": [
    "Q2 FY26 gross margin of ~49% included roughly 700bps of one-time tariff refunds; management's FY26 guide is ~40%, so reported margin is not a run rate.",
    "The $279M cash / no-debt figure is dated at the Q2 close and precedes the $175M Copra cash outflow that closed 2026-07-22.",
    "Buyback authorization totals $105M after a $40M addition, with ~$44M repurchased through 2026-07-22 — the issuer is an active buyer of its own shares.",
    "Q3 FY26 earnings date was not announced as of 2026-08-22; any date circulating before company confirmation is an estimate.",
    "read the Form 4 footnote before treating them as sales.",
    "No listed coconut-water pure-play peer exists, so sympathy reads must be borrowed from the wider functional-beverage complex."
  ],
  "body_markdown": "## Current Thesis\nQ2 FY26 on **2026-07-23** delivered — net sales **$216.2M, +28.1% YoY**, diluted EPS **$0.82** against roughly **$0.55** consensus, adjusted EBITDA **$67.2M (31% of net sales)** versus $29M (17%) a year earlier, and a full-year raise to **$790–805M / $154–161M adjusted EBITDA** from the late-April guide of $720–735M / $132–138M.\n\nWhat has changed since the last update is the shape of the tape, not the fundamentals. On **2026-08-07** the stock closed **$62.25** with RSI(14) at **27.5**. On **2026-08-21** it closed **$63.35** with RSI(14) at **49.9** — the oversold reading was worked off by roughly ten sessions of time and about 1.8% of price, which is repair through sideways drift rather than a reclaim. The stock sits **-24.6%** below the **$84.02** adjusted 52-week high, with a three-month price change of **-16.7%**.\n\nThe narrative is **saturated**, dated by the 2026-07-23 reaction and unchanged by the four weeks since. An unambiguous beat, a $175M acquisition and a raised guide produced a marginal new high and then supply; the only news item inside the last 30 days is a generic aggregator list (**2026-08-13**, \"12 Consumer Staples Stocks Moving In Thursday's After-Market Session\"). Attention has drained without price recovering. What is being priced now is whether 2026 profitability is a run rate or a tariff-refund-flattered peak.\n\n## Bull Case\n- **Q2 FY26 (2026-07-23): net sales $216.2M, +28.1% YoY**, with growth in both branded and private-label coconut water.\n- **Diluted EPS $0.82 vs ~$0.55 consensus; net income $49.5M vs $23.0M** in the year-ago quarter.\n- **Guidance raised twice inside one quarter** — late April to $720–735M, then 2026-07-23 to **$790–805M** net sales and **$154–161M** adjusted EBITDA.\n- **The issuer is buying**: authorization expanded by $40M to **$105M**, with approximately **$44M repurchased through 2026-07-22**, executed while the stock was near its high.\n- **Post-print sell-side did not blink.** The five most recent published actions listed by stockanalysis.com as of 2026-08-22: Piper Sandler Buy **$89** (2026-07-24), Bank of America Buy **$85** (2026-07-24), Wells Fargo Buy **$85** (2026-07-24), Needham Hold with no target (2026-07-24), Morgan Stanley Hold **$68** (2026-07-28). Average target **$83.89** across 11 analysts. No target has been cut in the four weeks since 2026-07-28 — the downward-convergence risk flagged in prior coverage has not yet been observed.\n- **Copra, Inc. Closed 2026-07-22 for $175M cash** — a super-premium Thai Nam Hom producer, adding a price tier above the core brand and owned supply.\n- **Multiple compressed while earnings rose**: trailing P/E **34.35** at the 2026-08-07 close, against the ~49x carried into the July print.\n\n## Bear Case\n- **The 49% Q2 gross margin is not the run rate.** Tariff refunds contributed roughly **700bps to Q2 gross margin** and ~300bps year-to-date; management's own FY26 guide is **~40%**. The headline profitability that drove the July high contains a component the company has already guided away from.\n- **The binary came and went.** It resolved bullish on every reported line on 2026-07-23 and the stock is a quarter below its post-print high a month later. Good news absorbed at a new high is distribution behaviour, and nothing since has produced a bid.\n- **The catalyst void is long.** The Q3 FY26 date was still unannounced as of **2026-08-22**; on the Q1 (2026-04-29) and Q2 (2026-07-23) cadence, a late-October print is the working estimate. That leaves roughly ten weeks with no dated company event.\n- **Balance-sheet strength is dated.** The **$279M cash, no debt** figure is the Q2 close and precedes the $175M Copra outflow.\n- **Private-label growth cuts both ways.** Mix shifting toward retailer own-brand dilutes the branded pricing-power story the multiple rests on.\n\n## Setup & Price Structure\n- The **~$60 shelf** — the late-April Q1 breakaway gap — is the last structure below spot. It has held on a closing basis through the entire post-print drawdown, including the 2026-08-07 low-RSI session.\n- The stock has made no attempt at the mid-$70s since the print. The recovery from $62.25 to $63.35 over ten sessions with RSI moving 27.5 → 49.9 describes range repair, and a range needs a reason to break upward that the calendar does not currently supply.\n- **Positioning observables, stated as observables**: the issuer is an active buyer under a $105M authorization; sell-side targets sit $4.65 to $25.65 above the 2026-08-21 close with zero cuts since 2026-07-28; there is no earnings date inside 30 days; retail-flow coverage clustered *before* the print (2026-06-03 Benzinga on IBD SwingTrader buying; 2026-05-15 Benzinga flagging RSI above 70) and has gone quiet since.\n- **Insider filings, read correctly**: Form 4s dated **2026-08-15** show CMO Jane Prior and CCO Charles van Es each with **10,801 shares withheld at $65.21** for tax on RSU settlement. These are non-discretionary dispositions tied to vesting, and the footnote says so — they are a dated price mark inside the range, not a sale decision.\n\n## Catalyst Calendar (next 30 days)\n\n- **2026-08-22 to 2026-09-21 — no company-confirmed event.** The Q3 FY26 earnings date had not been announced as of 2026-08-22.\n- **~2026-10-29 (est.), outside the window** — Q3 FY26 print. First quarter without the tariff-refund benefit and first read on Copra's contribution.\n\n## Elapsed catalysts\n\n- **~September 2026 (unconfirmed)** — consumer-staples conference season. Vita Coco presented at the Goldman Sachs Global Staples Forum in May 2026, so a September appearance is plausible; no such participation was confirmed by the company as of 2026-08-22, and treating it as scheduled would be wrong. *(passed 4d ago)*\n\n## What Would Change Our Mind\nThe structure that matters is the late-April gap shelf near $60. Losing it on **a weekly close below $60** fills that gap and retraces the entire post-Q1 re-rate, at which point the July beat-and-raise has been fully rejected by the market and the saturated label hardens into a broken one. Second, the margin question: Q3 FY26 gross margin printing at or under the ~40% FY guide, or management quantifying an incremental tariff *cost* rather than a refund, would confirm that 2026's reported profitability was a policy artifact.\n\nWhat would argue the other way is equally specific: a reclaim of the mid-$70s on expanding volume, a Q3 print with gross margin holding above the ~40% guide with Copra revenue quantified, or the buyback consuming a visible share of the remaining ~$61M authorization at these levels. Absent one of those, a stock -24.6% from its high with no dated catalyst for roughly ten weeks is a waiting problem, and there is no penalty for waiting for the base to form.\n\n## Correlation Notes\n- **No listed coconut-water pure-play exists.** Sympathy reads have to be borrowed from the wider functional-beverage complex, which imports beta that has nothing to do with coconut supply or Vita Coco's private-label book.\n- **Tariff policy is a direct P&L line here, not a macro overlay.** The ~700bps Q2 gross-margin contribution from refunds means US import-duty rulings on Southeast Asian beverage inputs move this income statement more than they move a domestically sourced staple.\n- **Copra ties the story to Thai Nam Hom sourcing**, adding crop, freight and FX exposure concentrated in Thailand and the Philippines.\n- **Private-label revenue tracks retailer own-brand programs**, so shelf-reset and club-channel decisions at large grocers are a transmission channel distinct from branded beverage demand.\n- **Trailing P/E 34.35 at the 2026-08-07 close** keeps the name in the high-multiple small-cap growth bucket, where flow rather than fundamentals sets the marginal price in a catalyst void.",
  "first_seen": "2026-05-15",
  "last_analyzed": "2026-08-22T07:39:52+00:00",
  "last_synthesized": "2026-08-22",
  "last_update_source": "watchlist_research",
  "license": "Content © FrontierPicks. Cite the canonical URL."
}